ATE204880T1 - N-acyldipeptide, und pharmazeutische präparate davon - Google Patents

N-acyldipeptide, und pharmazeutische präparate davon

Info

Publication number
ATE204880T1
ATE204880T1 AT91116356T AT91116356T ATE204880T1 AT E204880 T1 ATE204880 T1 AT E204880T1 AT 91116356 T AT91116356 T AT 91116356T AT 91116356 T AT91116356 T AT 91116356T AT E204880 T1 ATE204880 T1 AT E204880T1
Authority
AT
Austria
Prior art keywords
chem
description
amino acid
meaning
formula
Prior art date
Application number
AT91116356T
Other languages
English (en)
Inventor
Slavko Prof Dr Pecar
Marija Sollner
Uros Dr Urleb
Danijel Dr Kikelj
Gasper Marc
Ales Prof Dr Krbavcic
Vlado Dr Kotnik
Branka Wraber-Herzog
Sasa Simcic
Alojz Dr Ihan
Lidija Mag Klamfer
Lucka Povsic
Zdravko Prof Dr Kopitar
Anton Dr Stalc
Original Assignee
Univ Ljubljani
Lek Tovarna Farmacevtskih
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ljubljani, Lek Tovarna Farmacevtskih filed Critical Univ Ljubljani
Application granted granted Critical
Publication of ATE204880T1 publication Critical patent/ATE204880T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/823—Immunogenic carrier or carrier per se
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT91116356T 1990-09-27 1991-09-25 N-acyldipeptide, und pharmazeutische präparate davon ATE204880T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU183090A YU183090A (sh) 1990-09-27 1990-09-27 Novi n-acildipeptidi, postopki za njihovo pripravo in farmacevtski pripravki, kojih vsebujejo

Publications (1)

Publication Number Publication Date
ATE204880T1 true ATE204880T1 (de) 2001-09-15

Family

ID=25555754

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91116356T ATE204880T1 (de) 1990-09-27 1991-09-25 N-acyldipeptide, und pharmazeutische präparate davon

Country Status (7)

Country Link
US (1) US5514654A (de)
EP (1) EP0477912B1 (de)
JP (1) JP2795421B2 (de)
AT (1) ATE204880T1 (de)
DE (1) DE69132707T2 (de)
SI (1) SI9011830B (de)
YU (1) YU183090A (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9301789A (es) * 1992-04-03 1993-10-01 Iaf Biochem Int Nuevos oligopeptidos lipofilicos con actividad inmunomoduladora.
SI9300212A (en) * 1993-04-22 1994-12-31 Univ Ljubljani Novel N-acyldipeptides, process for the preparation thereof and pharmaceutical composition containing the same
SG91244A1 (en) * 1996-06-24 2002-09-17 Givaudan Roure Int Malodour preventing agents
AUPO161196A0 (en) * 1996-08-13 1996-09-05 Commonwealth Scientific And Industrial Research Organisation Novel compounds
US6358504B1 (en) 1997-02-07 2002-03-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
AU1180200A (en) * 1999-11-12 2001-05-30 Fujimoto Brothers Co., Ltd. Antiinflammatory medicinal compositions
US20100183714A1 (en) * 2004-03-26 2010-07-22 Lek Pharmaceuticals D.D. Gastroresistant pharmaceutical dosage form comprising n-(2-(2- phthalimidoethoxy)-acetyl)-l-alanyl-d-glutamic acid (lk-423)
US20080124279A1 (en) * 2006-11-17 2008-05-29 Antoine Andremont Colonic delivery using Zn/pectin beads with a Eudragit coating
PE20140913A1 (es) 2010-11-15 2014-08-22 Abbvie Inc Inhibidores de nampt y rock
WO2017223337A1 (en) 2016-06-23 2017-12-28 Nutrivert Llc Methods to promote growth and improve feed conversion in animals
BR112022019202A2 (pt) 2020-03-26 2022-11-08 Nutrivert Llc Oligopeptídeo, composição farmacêutica, composição, e, método para reduzir a inflamação intestinal em um ser humano, para promover crescimento em um animal e para realçar conversão de alimento em um animal

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2460288A1 (fr) * 1979-06-29 1981-01-23 Rhone Poulenc Ind Nouveaux dipeptides, leur preparation et les medicaments qui les contiennent

Also Published As

Publication number Publication date
SI9011830B (sl) 1999-12-31
JP2795421B2 (ja) 1998-09-10
DE69132707T2 (de) 2002-06-20
YU183090A (sh) 1992-12-21
US5514654A (en) 1996-05-07
SI9011830A (en) 1997-10-31
DE69132707D1 (de) 2001-10-04
EP0477912A3 (en) 1992-08-12
EP0477912A2 (de) 1992-04-01
JPH06220087A (ja) 1994-08-09
EP0477912B1 (de) 2001-08-29

Similar Documents

Publication Publication Date Title
NO933376L (no) Morfinan-derivater og medisinsk anvendelse derav
TW330202B (en) Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals
AU557691B2 (en) 2-penem antibiotics and their oxa-aza-, and carba analogues
NO175256C (no) Analogifremgangsmåte til fremstilling av terapeutisk aktive 4-oksokinolin-3-karboksylsyrederivater
ATE204880T1 (de) N-acyldipeptide, und pharmazeutische präparate davon
EP0632031A4 (de)
IL107315A0 (en) 2-Saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and pharmaceutical compositions containing them
ES8609212A1 (es) Un procedimiento para la preparacion de derivados de etanolamina.
AU645090B2 (en) Novel N-Benzyl-N-Phenyl and -Phenalkyl-Thioureas
FI95247C (fi) Menetelmä lääkeaineina käytettävien 1,3-tiatsolidinien -karbonyylikarboksiamidien valmistamiseksi
DE69407709D1 (de) Carboxylatderivate mit einer die Phospholipase A2 hemmenden Aktivität
ATE146481T1 (de) Epoxysuccinamidsäurederivat
ATE163649T1 (de) Peptide, herstellung und deren verwendung
ATE46347T1 (de) Immunostimulierende peptide.
JPS56131571A (en) Novel hetero ring substituted carboxyamide and methyl amine compound
DK1078916T3 (da) Fremgangsmåde til fremstilling af N-acylaminosyreestere og N-acylaminoacetaler
YU48453B (sh) Novi trans-2-acilaminociklo heksiloksiacildipeptidi u obliku smeša svojih dijastereoizomera i u obliku čistih dijastereoizomera, postupci za njihovo dobijanje
FI872135A0 (fi) Foerfarande foer framstaellning av kefalosporinderivat.
BG50501A3 (bg) Метод за получаване на 1,5-бензтиазепинови производни
ATE44741T1 (de) 2-(n-substituierte guanidino)-4heteroarylthiazole als mittel gegen geschwuere.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties